After the Prescription: The Clinical Support Gap in Telehealth-Based GLP-1 Care.
Where this comes from
- Record sourced from PubMed, PMID 42206886.
- Also identified by DOI 10.2196/101874.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
GLP-1 medications offer promise for obesity management and are increasingly accessible via digital platforms. In this News and Perspectives article, JMIR Correspondent Anna Zucker reports on the gap in clinical support that could undermine their potential benefits.
Medical subject headings
- Glucagon-Like Peptide 1
- Telemedicine
- Obesity